


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.23%
-1.87%
+0.90%
+1.26%
THC
Tenet Healthcare
$229.90
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Investors confidence is positive
THC Price Performance
$189.92 (+21.05%)
$216.84 (+6.02%)
$203.04 (+13.23%)
$126.22 (+82.14%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Expands stock buyback program
Future
Future
Earnings are forecast to grow
Trading below its fair value
THC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
THC Street Sentiment is extremely bullish and have positive views on the near-term outlook
THC has Fair risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Dec 08, 2025
Reiterate
Overweight
Cantor Fitzgerald
Dec 03, 2025
Reiterate
Buy
Guggenheim
Nov 14, 2025
Reiterate
Overweight
JP Morgan
Nov 14, 2025
Reiterate
Overweight
Wells Fargo
Nov 04, 2025
Reiterate
Buy
Truist Securities
What is THC current stock price?
What are THC stock strengths?
What is THC Risk Level?
What is THC market cap and volume?
What is THC current Stock IQ?
Should I buy THC stock right now?
Is THC a Strong Buy right now?
What does a 'Strong Buy' rating mean for THC?
What does a 'Strong Sell' rating mean for THC?
What factors influence THC's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
THC
Tenet Healthcare
Current Price
$229.90

THC Price Performance
$189.92 (+21.05%)
$216.84 (+6.02%)
$203.04 (+13.23%)
$126.22 (+82.14%)
THC Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Expands stock buyback program
Future
Future
Earnings are forecast to grow
Trading below its fair value
THC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
THC Street Sentiment is extremely bullish and have positive views on the near-term outlook
THC has Fair risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
THC Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Investors confidence is positive
THC Latest Analysis
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It. Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So it is worth exploring what lies ahead for the stock.
Thu Feb 19, 2026
Advantage Announces Operations Update Conclusion of Strategic Review and 2025 Reserves. (TSX:)Operations and Commercial UpdateNet capital expenditures(a) were (b) during the year ended Production for the fourth quarter of 2025 averaged 79823 boe/d (408.3 mmcf/d natural gas 7372 bbls/d crude oil 938 bbls/d condensate and 3462 bbls/d NGLs) despite minor impacts from price-driven shut-ins in early October.Production in Delivered exceptional capital efficiencies with the top 9 Alberta Montney gas we
Thu Feb 12, 2026
Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline. THC tops Q4 estimates with strong EBITDA growth but 2026 guidance midpoint hints at a potential margin dip despite a higher revenue outlook.
Thu Feb 12, 2026
Tenet Healthcare Remains Compelling Even After A 17.3% Post-Earnings Surge.
Wed Feb 11, 2026
Tenet Healthcare Quarterly Profit Surges As Hospital Surgery Demand Grows. ) reported fourth-quarter sales of $5.527 billion up around 8.9% year over year.The hospitals and healthcare facilities operator beat the consensus of $5.472 billion. It also reported adjusted earnings of $4.70 per share up from $3.44 a year ago beating the consensus of $4.05.Adjusted EBITDA in the fourth quarter of 2025 was $1.183 billion compared to $1.048 billion a year ago. The upward momentum reflects strong growth i
Wed Feb 11, 2026
Tenet Healthcare (THC) Q4 Earnings and Revenues Surpass Estimates. Tenet (THC) delivered earnings and revenue surprises of 15.23% and 1.38% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Wed Feb 11, 2026
Tenet Healthcare Non-GAAP EPS of $4.70 beats by $0.65 revenue of $5.53B beats by $60M.
Wed Feb 11, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.